# An Efficacy and Safety Study of Omega-3-acid Ethyl Ester in Chinese Subjects With Hypertriglyceridemia.

> **NCT04756180** · PHASE3 · COMPLETED · sponsor: **Abbott** · enrollment: 248 (actual)

## Conditions studied

- Hypertriglyceridemia

## Interventions

- **DRUG:** Omega-3-acid ethyl ester or Placebo

## Key facts

- **NCT ID:** NCT04756180
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2019-04
- **Final completion:** 2019-04
- **Target enrollment:** 248 (ACTUAL)
- **Last updated:** 2021-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04756180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04756180, "An Efficacy and Safety Study of Omega-3-acid Ethyl Ester in Chinese Subjects With Hypertriglyceridemia.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04756180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*